Immunopathologic responses to non-lethal sepsis

Shock

Volumn 12, Issue 2, 1999, Pages 118-126

  Ebong, Samuel J ^a   Call, Douglas R ^a   Bolgos, Gerald ^a   Newcomb, David E ^a   Granger, Jill I ^a   O'Reilly, Michael ^a   Remick, Daniel G ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Chemokines; Cytokines; In vivo animal models; Inflammation; Rodents

Indexed keywords

ALPHA CHEMOKINE; AUTACOID; CHEMOKINE; CXCL1 PROTEIN, MOUSE; CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; HEMOGLOBIN; INTERLEUKIN 1; INTERLEUKIN 6; KERATINOCYTE DERIVED CHEMOKINES; KERATINOCYTE-DERIVED CHEMOKINES; MACROPHAGE INFLAMMATORY PROTEIN 2; MONOKINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BLOOD CELL COUNT; CELL COUNT; CHEMISTRY; CIRCADIAN RHYTHM; CYTOLOGY; DISEASE MODEL; FEMALE; LUNG LAVAGE; METABOLISM; MOTOR ACTIVITY; MOUSE; PATHOLOGY; PATHOPHYSIOLOGY; PERITONEUM; SEPSIS; SURVIVAL RATE; THERMOREGULATION; WEIGHT REDUCTION;

ANIMALS; BLOOD CELL COUNT; BODY TEMPERATURE REGULATION; BRONCHOALVEOLAR LAVAGE FLUID; CELL COUNT; CHEMOKINES; CHEMOKINES, CXC; CIRCADIAN RHYTHM; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMOGLOBINS; INFLAMMATION MEDIATORS; INTERLEUKIN-1; INTERLEUKIN-6; MICE; MICE, INBRED BALB C; MONOKINES; MOTOR ACTIVITY; PERITONEUM; SEPSIS; SURVIVAL RATE; TUMOR NECROSIS FACTOR-ALPHA; WEIGHT LOSS;

EID: 0033174324     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-199908000-00005     Document Type: Article

References (35)

1. Parillo JE: The cardiovascular pathophysiology of sepsis. Annu Rev Med 40:469-485, 1989.
2. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine [see comments]. Chest 101:1644-1655, 1992.
3. Eskandari MK, Bolgos G, Miller C, Nguyen DT, DeForge LE, Remick DG: Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia. J Immunol 148:2724-2730, 1992.
4. Tracey KJ, Fong Y, Hesse DG, Manogue KR, Lee AT, Kuo GC, Lowry SF, Cerami A: Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330:662-664, 1987.
5. Arend WP, Welgus HG, Thompson RC, Eisenberg SP: Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist. J Clin Invest 85:1694-1697, 1990.
6. Fisher CJ, Jr., Agosti JM, Opal SM, Lowry SF, Balk RA, Sadoff JC, Abraham E, Schein RM, Benjamin E: Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group. N Engl J Med 334:1697-1702, 1996.
7. Abraham E, Wunderink R, Silverman H, Perl TM, Nasraway S, Levy H, Bone R, Wenzel RP, Balk R, Allred R, et al.: Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group. JAMA 273:934-941, 1995.
8. Fisher CJ, Jr., Dhainaut JF, Opal SM, Pribble JP, Balk RA, Slotman GJ, Iberti TJ, Rackow EC, Shapiro MJ, Greenman RL, Reines HD, Shelly MP, Thompson BW, LaBrecque JF, Catalano MA, Knaus WA, Sadoff JC: Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group [see comments]. JAMA 271:1836-1843, 1994.
9. Wichterman KA, Baue AE, Chaudry IH: Sepsis and septic shock: a review of laboratory models and a proposal. J Surg Res 29:189-201, 1980.
10. Remick D, Manohar P, Bolgos G, Rodriguez J, Moldawer L, Wollenberg G: Blockade of tumor necrosis factor reduces lipopolysaccharide lethality, but not the lethality of cecal ligation and puncture. Shock 4:89-95, 1995.
11. Newcomb D, Bolgos G, Green L, Remick DG: Antibiotic treatment influences outcome in murine sepsis: mediators of increased morbidity. Shock 10:110-117, 1998.
12. Espevik T, Nissen Meyer J: A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J Immunol Methods 95:99-105, 1986.
13. Eskandari MK, Nguyen DT, Kunkel SL, Remick DG: WEHI 164 subclone 13 assay for TNF: sensitivity, specificity, and reliability. Immunol Invest 19:69-79, 1990.
14. Aarden LA, De Groot ER, Schaap OL, Lansdorp PM: Production of hybridoma growth factor by human monocytes. Eur J Immunol 17:1411-1416, 1987.
15. Ulich TR, Fann MJ, Patterson PH, Williams JH, Samal B, del Castillo J, Yin S, Guo K, Remick DG: Intratracheal injection of LPS and cytokines. V. LPS induces expression of LIF and LIF inhibits acute inflammation. Am J Physiol 267:L442-446 1994, 1994.
16. DeForge LE, Remick DG: Sandwich ELISA for detection of picogram quantities of interleukin-8. Immunol Invest 20:89-97, 1991.
17. Lundblad R, Sandven P, Giercksky KE: The physical nature of a large bowel perforation predicts severity of the subsequent inflammatory response. Shock 3:455-461, 1995.
18. Evans GF, Snyder YM, Butler LD, Zuckerman SH: Differential expression of interleukin-1 and tumor necrosis factor in murine septic shock models. Circ Shock 29:279-290, 1989.
19. Ayala A, Perrin MM, Kisala JM, Ertel W, Chaudry IH: Polymicrobial sepsis selectively activates peritoneal but not alveolar macrophages to release inflammatory mediators (interleukins-1 and -6 and tumor necrosis factor). Circ Shock 36:191-199, 1992.
20. Summerfield A, Knotig SM, McCullough KC: Lymphocyte apoptosis during classical swine fever: implication of activation-induced cell death. J Virol 72:1853-1861, 1998.
21. Ayala A, Herdon CD, Lehman DL, Ayala CA, Chaudry IH: Differential induction of apoptosis in lymphoid tissues during sepsis: variation in onset, frequency, and the nature of the mediators. Blood 87:4261-4275, 1996.
22. Hotchkiss RS, Swanson PE, Cobb JP, Jacobson A, Buchman TG, Karl IE: Apoptosis in lymphoid and parenchymal cells during sepsis: findings in normal and T- and B-cell-deficient mice [see comments]. Crit Care Med 25:1298-1307, 1997.
23. Ayala A, Xin Xu Y, Ayala CA, Sonefeld DE, Karr SM, Evans TA, Chaudry IH: Increased mucosal B-lymphocyte apoptosis during polymicrobial sepsis is a Fas ligand but not an endotoxin-mediated process. Blood 91:1362-1372, 1998.
24. Williams RC, Jr., Koster FT, Kilpatrick KA: Alterations in lymphocyte cell surface markers during various human infections. Am J Med 75:807-816, 1983.
25. Cheadle WG, Pemberton RM, Robinson D, Livingston DH, Rodriguez JL, Polk HC, Jr.: Lymphocyte subset responses to trauma and sepsis. J Trauma 35:844-849, 1993.
26. Sehgal PB: Interleukin-6: a regulator of plasma protein gene expression in hepatic and non-hepatic tissues. Mol Biol Med 7:117-130, 1990.
27. Pinsky MR, Vincent JL, Deviere J, Alegre M, Kahn RJ, DuPont E: Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest 103:565-575, 1993.
28. Damas P, Ledoux D, Nys M, Vrindts Y, De Groote D, Franchimont P, Lamy M: Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. Ann Surg 215:356-362, 1992.
29. Calandra T, Gerain J, Heumann D, Baumgartner JD, Glauser MP: High circulating levels of interleukin-6 in patients with septic shock: evolution during sepsis, prognostic value, and interplay with other cytokines. The Swiss-Dutch J5 Immunoglobulin Study Group. Am J Med 91:23-29, 1991.
30. Casey LC, Balk RA, Bone RC: Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome [see comments]. Ann Intern Med 119:771-778, 1993.
31. Friedland JS, Porter JC, Daryanani S, Bland JM, Screaton NJ, Vesely MJ, Griffin GE, Bennett ED, Remick DG: Plasma proinflamrnatory cytokine concentrations, Acute Physiology and Chronic Health Evaluation (APACHE) III scores and survival in patients in an intensive care unit [see comments]. Crit Care Med 24:1775-1781, 1996.
32. Keel M, Ungethum U, Steckholzer U, Niederer E, Hartung T, Trentz 0, Ertel W: Interleukin-10 counterregulates proinflammatory cytokine-induced inhibition of neutrophil apoptosis during severe sepsis. Blood 90:3356-3363, 1997.
33. Patton JHJMD, Lyden SPMD, Ragsdale DNBA, Croce MAMD, Fabian TCMD, Proctor KGP: Granulocyte colony-stimulating factor improves host defense to resuscitated shock and polymicrobial sepsis without provoking generalized neutrophil-mediated damage. J Trauma 44:750-759, 1998.
34. Lentsch AB, Yoshidome H, Cheadle WG, Miller FN, Edwards MJ: Chemokine involvement in hepatic ischemia/reperfusion injury in mice: roles for macrophage inflammatory protein-2 and KC [corrected and republished article originally printed in Hepatology 1998 Feb.27(2):507-12]. Hepatology 27:1172-1177, 1998.
35. Grigg JM, Savill JS, Sarraf C, Haslett C, Silverman M: Neutrophil apoptosis and clearance from neonatal lungs. Lancet 338:720-722, 1991.